Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $304.26 | 5 | 96.0% |
| Education | $12.70 | 1 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inspire Medical Systems, Inc. | $151.83 | 1 | $0 (2023) |
| Galderma Laboratories, L.P. | $99.52 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $37.69 | 2 | $0 (2023) |
| Insmed, Inc. | $15.22 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $169.62 | 2 | Inspire Medical Systems, Inc. ($151.83) |
| 2022 | $15.22 | 1 | Insmed, Inc. ($15.22) |
| 2021 | $19.90 | 1 | GlaxoSmithKline, LLC. ($19.90) |
| 2019 | $112.22 | 2 | Galderma Laboratories, L.P. ($99.52) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $151.83 | General |
| Category: NEUROLOGY | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Respiratory | ||||||
| 03/10/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/01/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $99.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,040 | 2,361 | $412,762 | $162,844 |
| 2022 | 28 | 2,187 | 2,557 | $422,586 | $175,157 |
| 2021 | 30 | 2,208 | 2,583 | $435,322 | $201,414 |
| 2020 | 28 | 2,364 | 2,821 | $476,203 | $207,518 |
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 390 | 495 | $74,250 | $45,646 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 382 | 436 | $45,420 | $27,211 | 59.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 113 | $47,460 | $18,724 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $23,000 | $10,972 | 47.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 130 | $17,810 | $8,029 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 60 | $12,460 | $6,775 | 54.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 268 | 295 | $20,629 | $5,889 | 28.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 46 | 46 | $21,160 | $4,785 | 22.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 55 | 55 | $12,705 | $4,743 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $8,250 | $4,548 | 55.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 63 | 63 | $56,121 | $4,066 | 7.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 153 | 164 | $13,120 | $4,063 | 31.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 35 | $9,065 | $3,564 | 39.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 36 | 36 | $8,640 | $3,293 | 38.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $4,060 | $2,143 | 52.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,334 | $1,902 | 35.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 19 | $3,705 | $1,771 | 47.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 17 | 17 | $1,360 | $716.48 | 52.7% |
| 76604 | Ultrasound scan of chest | Office | 2023 | 14 | 16 | $1,920 | $675.15 | 35.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 17 | 17 | $1,020 | $551.36 | 54.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 14 | 14 | $686.00 | $408.86 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $448.00 | $391.95 | 87.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $2,508 | $373.49 | 14.9% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 15 | 15 | $735.00 | $282.25 | 38.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 19 | 19 | $760.00 | $281.20 | 37.0% |
About Dr. Joseph Khoury, M.D
Dr. Joseph Khoury, M.D is a Pulmonary Disease healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053357053.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Khoury, M.D has received a total of $316.96 in payments from pharmaceutical and medical device companies, with $169.62 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($304.26).
As a Medicare-enrolled provider, Khoury has provided services to 8,799 Medicare beneficiaries, totaling 10,322 services with total Medicare billing of $746,933. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Lynchburg, VA
- Active Since 06/20/2006
- Last Updated 08/24/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1053357053
Products in Payments
- INSPIRE (Device) $151.83
- NUCALA (Biological) $37.69
- Arikayce (Drug) $15.22
- ZERBAXA (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lynchburg
John Plankeel, M.d, M.D
Pulmonary Disease — Payments: $97,297
Michael Milam, M.d, M.D
Pulmonary Disease — Payments: $7,325
Dr. Prema Madhuri Pamireddy, M.d, M.D
Pulmonary Disease — Payments: $3,049
Albert Baker, M.d, M.D
Pulmonary Disease — Payments: $2,273
Lisa Geier, N.p, N.P
Pulmonary Disease — Payments: $44.25
Carol Driskill, N.p, N.P
Pulmonary Disease